Back to Top
Charles H. Hood Foundation | BioROSA
By identifying innovative pediatric advancements and providing funding in the critical phases of development, we are able to expedite high-impact breakthroughs that improve the health and lives of millions.
portfolio_page-template-default,single,single-portfolio_page,postid-18078,ajax_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-1.0.0,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-4.12,vc_responsive

Program Related Investment

BioROSA Technologies

Today, autism diagnosis is achieved through time-consuming and non-scalable behavioral evaluations.  BioROSA seeks to transform diagnosis from behavior to biology and to detect Autism Spectrum Disorder (ASD) before behavioral onset by developing a rapid proprietary, blood-based, metabolomics and machine learning platform.  This will improve patient prognosis, enable earlier intervention, support clinical trials, and reduce healthcare costs through a predictive medicine model of care.

Learn more.